Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,824 | 5,961 | 6,799 | 7,739 | 5,069 |
| Other current assets | 150 | 216 | 323 | 13 | 77 |
| TOTAL | $5,093 | $6,307 | $7,243 | $7,890 | $5,229 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 26 | 0 | 0 | 0 |
| TOTAL | $N/A | $26 | $N/A | $N/A | $N/A |
| Total Assets | $5,093 | $6,334 | $7,243 | $7,890 | $5,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 226 | 232 | 162 | 149 | 190 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 11 |
| Other current liabilities | 77 | 27 | 214 | 94 | 16 |
| TOTAL | $303 | $259 | $376 | $242 | $217 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $303 | $259 | $376 | $242 | $217 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,375 | 1,375 | 1,375 | 1,366 | 1,354 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -37,082 | -35,053 | -33,814 | -32,081 | -30,354 |
| TOTAL | $4,790 | $6,075 | $6,866 | $7,648 | $5,012 |
| Total Liabilities And Equity | $5,093 | $6,334 | $7,243 | $7,890 | $5,229 |